Ignite Creation Date:
2024-05-06 @ 12:48 AM
Last Modification Date:
2024-10-26 @ 10:55 AM
Study NCT ID:
NCT01667744
Status:
WITHDRAWN
Last Update Posted:
2022-12-09
First Post:
2012-08-12
Brief Title:
Citalopram for SxUtil in Acute Coronary Syndrome Patients
Sponsor:
Henry Ford Health System
Organization:
Henry Ford Health System
Study Overview
Official Title:
Citalopram for SxUtil in Acute Coronary Syndrome Patients
Status:
WITHDRAWN
Status Verified Date:
2022-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
unfunded
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Symptoms chest pain shortness of breath dizziness etc and treatment usage doctor or emergency room visits testing hospital days etc in patients with Acute Coronary Syndromes are known to be related to emotional distress Anxiety Depression and Anger In addition behavioral treatment of emotional distress is known to decrease symptoms and treatment usage The present protocol tests whether the addition of a medication known to reduce emotional distress can also reduce symptoms and treatment usage
This will done by recruiting patients with ACS during their hospital stay randomizing them to receive citalopram or placebo and then examining their symptoms and treatment usage at 6 months
This will done by recruiting patients with ACS during their hospital stay randomizing them to receive citalopram or placebo and then examining their symptoms and treatment usage at 6 months
Detailed Description:
Not applicable Study not funded
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None